Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Short

Showing results (411-420 of 659) with videos related to

Pageof 66
Sort By:
Blood Cancer Journal|October 21, 2025
Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALLNicholas J Short, Elias Jabbour, Walid Macaron, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive LeukemiaRita Assi, Hagop Kantarjian, Nicholas J Short, et al.
Menopause (New York, N.Y.)|August 5, 1998
Management of postmenopausal osteoporosis for primary careP Miller, B Lukert, S Broy, et al.
American Journal of Hematology|April 12, 2024
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapyNicholas J Short, Elias Jabbour, Lewis F Nasr, et al.
American Journal of Hematology|January 6, 2025
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaHagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
Nature|March 22, 2018
De novo mutations in regulatory elements in neurodevelopmental disordersPatrick J Short, Jeremy F McRae, Giuseppe Gallone, et al.
Environment International|August 31, 2024
Chemical and non-chemical stressors in a postpartum cohort through wristband and self report data: Links between increased chemical burden, economic, and racial stressElise Hickman, Jenna Frey, Amanda Wylie, et al.
Cancer|April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemiaHagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Leukemia & Lymphoma|June 1, 2026
Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoringTrevor Jamison, Elias Jabbour, Omer Karrar, et al.
Frontiers in Oncology|February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysisJacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Pageof 66

Showing results (411-420 of 659) with videos related to

Sort By:
Pageof 66
Blood Cancer Journal|October 21, 2025
Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALLNicholas J Short, Elias Jabbour, Walid Macaron, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 21, 2017
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive LeukemiaRita Assi, Hagop Kantarjian, Nicholas J Short, et al.
Menopause (New York, N.Y.)|August 5, 1998
Management of postmenopausal osteoporosis for primary careP Miller, B Lukert, S Broy, et al.
American Journal of Hematology|April 12, 2024
Characteristics and outcomes of patients with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia after failure of a frontline ponatinib-containing therapyNicholas J Short, Elias Jabbour, Lewis F Nasr, et al.
American Journal of Hematology|January 6, 2025
Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaHagop Kantarjian, Nicholas J Short, Nitin Jain, et al.
Nature|March 22, 2018
De novo mutations in regulatory elements in neurodevelopmental disordersPatrick J Short, Jeremy F McRae, Giuseppe Gallone, et al.
Environment International|August 31, 2024
Chemical and non-chemical stressors in a postpartum cohort through wristband and self report data: Links between increased chemical burden, economic, and racial stressElise Hickman, Jenna Frey, Amanda Wylie, et al.
Cancer|April 9, 2026
Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemiaHagop Kantarjian, Wei Qiao, Nitin Jain, et al.
Leukemia & Lymphoma|June 1, 2026
Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoringTrevor Jamison, Elias Jabbour, Omer Karrar, et al.
Frontiers in Oncology|February 2, 2026
Case Report: FIA plus venetoclax in a patient on hemodialysisJacob E Herstein, Kayleigh R Marx, J Michael Savoy, et al.
Pageof 66